NUCLEAR MEDICINE TUMOR LOCALIZATION/WHOLE-BODY

PROCEDURE: Following the IV administration of indium-111 Zevalin, anterior and posterior images were obtained at two hours and 48 hours postinjection.

DATE OF INDIUM-111 ZEVALIN INJECTION: 10/03/05

DATES OF IMAGING: 10/03/05

DOSE: [...] mCi

CLINICAL HISTORY: The patient is a [...]-year-old [fe]male with a history of relapsing non-Hodgkin's lymphoma. Now referred for an indium- 111 Zevalin. Diagnostic scan prior to possible treatment with Yttrium-90 Zevalin.

FINDINGS:

The early images obtained at two hours postinjection show normal distribution of indium- 111/Cevalin in the blood pool, liver, spleen, and kidneys.

Delayed images obtained at 48 hours after injection show normal uptake in the liver, spleen, and bladder. Multiple foci of increased tracer uptake consistent with the patient's known adenopathy are identified in the [...].

CONCLUSION:

1. Normal blood pool activity is identified on the early images. 

2. Multiple foci of abnormally increased tracer uptake as outlined above and consistent with patient's known disease are identified on the delayed images.

I, [...], M.D., Ph.D., have reviewed this Nuclear Medicine study personally, and am in full agreement with the findings of the report presented here.